Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Fresenius Medical Care, listed under the ticker FME, is a global provider of dialysis services and products for individuals diagnosed with chronic kidney failure. Founded in 1996 and headquartered in Bad Homburg, Germany, the company operates in the healthcare sector. Beyond dialysis, Fresenius Medical Care offers a range of other services, including hospital management and related healthcare services, advancing its position as a comprehensive healthcare provider internationally.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Fresenius Medical Care AGJohnson & Johnson
Last price
€37.91$262.92
Currency
EUR
USD
€9.9B$630B
11.2430.31
€3.35$8.63
0.830.23
€1.49$5.28
3.96%2.05%
Sector
HealthHealth
Employees
107,226138,200
Ticker
€FME$JNJ
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €FME or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.